3-BETA-ACETOXY-16-BETA-[4-(4-ETHYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
Compound with spectra: 1 NMR
![3-BETA-ACETOXY-16-BETA-[4-(4-ETHYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL](/api/compound/Dta1LvtqgV.png?ph=true&h=300&w=458 "3-BETA-ACETOXY-16-BETA-[4-(4-ETHYLPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL")
| SpectraBase Compound ID | Dta1LvtqgV |
|---|---|
| InChI | InChI=1S/C32H43N3O3/c1-5-21-6-8-22(9-7-21)29-19-35(34-33-29)18-23-16-28-26-11-10-24-17-25(38-20(2)36)12-14-31(24,3)27(26)13-15-32(28,4)30(23)37/h6-10,19,23,25-28,30,37H,5,11-18H2,1-4H3/t23-,25+,26-,27+,28+,30+,31+,32+/m1/s1 |
| InChIKey | XJAHUZSTFAZMNK-RNNOINMMSA-N |
| Mol Weight | 517.7 g/mol |
| Molecular Formula | C32H43N3O3 |
| Exact Mass | 517.330442 g/mol |
| Enantiomer InChIKey | XJAHUZSTFAZMNK-IOEUMULDSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | CDCl3 |
3-BETA-ACETOXY-16-BETA-[4-(4-FLUOROPHENYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-PHENYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-[4-(3-TOLYL)-1H-1,2,3-TRIAZOL-1-YLMETHYL]-ANDROST-5-EN-17-BETA-OL
3-BETA-ACETOXY-16-BETA-(4-CYCLOPROPYL-1H-1,2,3-TRIAZOL-1-YLMETHYL)-ANDROST-5-EN-17-BETA-OL
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-ALPHA-DIOL-DIACETATE
3,17a-Diacetoxy-16a-methyleneacetoxy.delta. 5(6)-androsten
16-ALPHA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
16-ALPHA-ACETYLOXYMETHYL-ANDROST-5-EN-3-BETA-17-ALPHA-DIOLACETATE
16-BETA-(ACETYLOXYMETHYL)-ANDROST-5-EN-3-BETA-17-BETA-DIOLACETATE
(16R) Ethyl 3,16-diacetoxy-20-methyl-24-nor-chol-5-en-23-oate
| Title | Journal or Book | Year |
|---|---|---|
| Synthesis and In Vitro Antiproliferative Activity of Novel Androst-5-ene Triazolyl and Tetrazolyl Derivatives | Molecules | 2011 |